New RSV Shot For Infants In Short Supply

USA – A new shot for infants against RSV is in short supply. That’s according to U.S. Health officials who told doctors they should prioritize giving the drug to babies at the highest risk of severe disease.

In an advisory, The Centers for Disease Control and Prevention told doctors infants less than 6 months who have chronic lung disease or other underlying conditions should be given priority.

The new one-time shot is a lab-made antibody that helps the immune system fight off the virus. Sold under the brand name Beyfortus, the drug was developed by Astrazeneca and Sanofi.